688180 君實生物
按盤價 
41.360 +0.590 (+1.447%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.345 | -14.720 | -19.689 | -27.454 | -27.404 |
| 總資產報酬率 ROA (%) | -0.155 | -7.556 | -11.579 | -19.107 | -20.243 |
| 投入資產回報率 ROIC (%) | -0.177 | -8.887 | -14.041 | -22.727 | -24.558 | 邊際利潤分析 |
| 銷售毛利率 (%) | 79.763 | 81.328 | 78.921 | 63.996 | 65.304 |
| 營業利潤率 (%) | -3.936 | -40.004 | -68.717 | -163.551 | -183.414 |
| 息稅前利潤/營業總收入 (%) | -0.273 | -38.344 | -69.686 | -170.296 | -189.759 |
| 淨利潤/營業總收入 (%) | -5.979 | -40.401 | -70.836 | -168.759 | -177.784 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 358.301 | 92.443 | 93.369 | 92.680 | 98.964 |
| 價值變動淨收益/利潤總額(%) | -284.159 | 4.809 | 5.247 | 3.018 | 1.913 |
| 營業外收支淨額/利潤總額(%) | 24.456 | 2.327 | 1.380 | 1.375 | 0.421 | 償債能力分析 |
| 流動比率 (X) | 2.139 | 1.604 | 1.718 | 2.285 | 4.086 |
| 速動比率 (X) | 1.934 | 1.398 | 1.483 | 2.064 | 3.746 |
| 資產負債率 (%) | 56.966 | 51.087 | 44.981 | 35.461 | 22.153 |
| 帶息債務/全部投入資本 (%) | 46.768 | 36.758 | 30.453 | 18.739 | 10.697 |
| 股東權益/帶息債務 (%) | 101.118 | 152.932 | 214.602 | 411.315 | 819.634 |
| 股東權益/負債合計 (%) | 73.135 | 95.332 | 120.838 | 177.791 | 340.888 |
| 利息保障倍數 (X) | -0.055 | -14.677 | 9,401.884 | 38.142 | 34.070 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 59.860 | 73.217 | 91.745 | 86.422 | 189.637 |
| 存貨周轉天數 (天) | 347.674 | 446.650 | 491.996 | 378.341 | 386.772 |
| 備註： | 即時報價更新時間為 28/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
